Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Remimazolam for Colonoscopy in IBD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update for remimazolam used during colonoscopy in patients with inflammatory bowel disease; recruitment is not yet ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Humanitas Clinical and Research Center | Conditions: IBD (Inflammatory Bowel Disease) | Phase 4 | Status: NOT_YET_RECRUITING